Atıf Formatları
The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Salman Et Al. , "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data," DERMATOLOGIC THERAPY , vol.32, no.4, 2019

Salman, A. Et Al. 2019. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data. DERMATOLOGIC THERAPY , vol.32, no.4 .

Salman, A., Demir, G., & BEKİROĞLU, G. N., (2019). The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data. DERMATOLOGIC THERAPY , vol.32, no.4.

Salman, ANDAÇ, Gizem Demir, And GÜLNAZ NURAL BEKİROĞLU. "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data," DERMATOLOGIC THERAPY , vol.32, no.4, 2019

Salman, ANDAÇ Et Al. "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data." DERMATOLOGIC THERAPY , vol.32, no.4, 2019

Salman, A. Demir, G. And BEKİROĞLU, G. N. (2019) . "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data." DERMATOLOGIC THERAPY , vol.32, no.4.

@article{article, author={ANDAÇ SALMAN Et Al. }, title={The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data}, journal={DERMATOLOGIC THERAPY}, year=2019}